Children's Health Defense ByÂ
Hospitalized COVID-19 patients treated with hydroxychloroquine (HCQ) alone, or HCQ plus the antibiotic azithromycin, had significantly lower mortality than those not receiving the drugs, according to a study released this month in New Microbes and New Infections.
Researchers in Belgium that just 16.7% of COVID-19 patients given HCQ, with or without azithromycin, died within 28 days compared to 25.9% among those not taking HCQ â a 35% lower mortality.
After adjusting for age differences, the risk of death was still 24% lower for HCQ-treated hospitalized patients.
The survival benefit was seen across all ages and was statistically significant…
